Simultaneous magnetically directed drug convection and MR imaging

Area of Science:

• Biomaterials Science
• Nanotechnology
• Biomedical Engineering

Background:

• Superparamagnetic iron oxide nanoparticles (IO NPs) are increasingly investigated for diverse biomedical applications.
• Surface modification of IO NPs with biocompatible polymers is crucial for enhancing their integration into biological systems.
• Understanding the behavior of protein-loaded nanoparticles under external stimuli is key for developing targeted therapies.

Purpose of the Study:

• To synthesize and characterize polymer-modified iron oxide core-shell nanoparticles (IO cs-NPs).
• To investigate the mass transport and protein release behavior of these nanoparticles under a magnetic field.
• To evaluate the potential of these nanoparticles for magnetically directed drug convection.

Main Methods:

• Synthesis of iron oxide nanocomposites surface-modified with biocompatible polymers.
• Physisorption of bovine serum albumin (BSA) onto IO NPs with an excipient during freeze-drying.
• In vitro mass transport studies using agarose gels and an MRI instrument's gradient magnetic field.
• In vivo model system studies using an egg to simulate biological fluid transport.

Main Results:

• Co-migration of PEG-modified IO cs-NPs with BSA was observed during mass transport under a magnetic field.
• Protein separation from the core was noted for some other modified cs-IO nanoparticles.
• Successful demonstration of proof-of-concept for magnetically directed drug convection using IO cs-NPs.

Conclusions:

• Polymer-modified iron oxide core-shell nanoparticles show potential for magnetically guided drug delivery.
• The choice of surface modification (e.g., PEG) influences nanoparticle-protein co-migration under magnetic fields.
• These findings support the advancement of IO NPs for targeted convection-based therapies in biomedical applications.